Presentation Information

[3S14a-04]DXd ADC Technology: Advancements in Daiichi Sankyo's Approach to Anti-Cancer Therapeutics

Kento Tanaka (Daiichi Sankyo Co., Ltd.)
キーテクノロジー:Antibody Drug Conjugate

Keywords:

Antibody Drug Conjugate

Password required to view


Comment

To browse or post comments, you must log in.Log in